Cannabis and psychiatric disorders: it is not only addiction (Q22242611)

The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells.

Europe PubMed Central

title

Cannabis and psychiatric disorders: it is not only addiction (English)

0 references

2

Dagmar Koethe

Dagmar

Koethe

1 reference

7 February 2023

F. Markus Leweke

1

F Markus

Leweke

1 reference

7 February 2023

language of work or name

English

0 references

publication date

June 2008

0 references

published in

Addiction Biology

0 references

volume

13

0 references

issue

2

0 references

page(s)

264-275

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Causal association between cannabis and psychosis: examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The seed and the soil: effect of dosage, personality and starting state on the response to delta 9 tetrahydrocannabinol in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Substance abuse in first-episode bipolar I disorder: indications for early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

In silico patent searching reveals a new cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis abuse as a risk factor for depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Longitudinal study of co-occurring psychiatric disorders and substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Exploring the association between cannabis use and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis use and psychosocial adjustment in adolescence and young adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Reasons for increased substance use in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis use and expression of mania in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The consequences in young adulthood of adolescent drug involvement. An overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The effects of tetrahydrocannabinol on the recognition of emotionally charged words: an analysis using event-related brain potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

A longitudinal study of cannabis use and mental health from adolescence to early adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabidiol: an overview of some pharmacological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Impact of complex genetic variation in COMT on human brain function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis use and psychosis: a longitudinal population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The involvement of glutamate in the pathophysiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Rimonabant: a novel selective cannabinoid-1 receptor antagonist for treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis use and mental health in young people: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The impact of substance abuse on the course of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis and neurodevelopment: implications for psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis use and age at onset of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Endocannabinoid system and stress and anxiety responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

The development of suicide ideation and attempts: an epidemiologic study of first graders followed into young adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Endocannabinoid signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

Cannabis abuse and the course of recent-onset schizophrenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

The short-term consequences of early onset cannabis use

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Effects of cannabidiol in animal models predictive of antipsychotic activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Cannabinoid modulation of rat pup ultrasonic vocalizations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

The endocannabinoid system drives neural progenitor proliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Elevated endogenous cannabinoids in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Substance abuse and bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Cannabis and Anxiety and Depression in Young Adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Proceedings: Effects of chronic and acute cannabis treatment upon thiopentone anaesthesia in rabbits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Effects of ipsapirone and cannabidiol on human experimental anxiety

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021

Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00106.X

7 January 2021